DSGN
Design Therapeutics, Inc.$12.89+0.09 (+0.66%)Prev Close$12.81·MCap$772.8M·P/E—·Vol115.2K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
1
$2.95M
◆
Net Activity
Net Seller
$2.95M
●
Active Insiders
1
last 12 mo
Over the past 12 months, insider activity at Design Therapeutics, Inc. (DSGN) has been exclusively selling, with 0 insider purchases totaling $0.00 and 1 insider sale totaling $2.95M. The most recent insider transaction was by William Arsani (Director), who sold $2.95M worth of shares on Aug 13, 2025. Design Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $772.8M.
DSGN Insider Trading Activity
DSGN Insider Buying Activity
The following table shows recent insider purchases of Design Therapeutics, Inc. (DSGN) stock reported via SEC Form 4 filings.
DSGN Insider Selling Activity
The following table shows recent insider sales of Design Therapeutics, Inc. (DSGN) stock reported via SEC Form 4 filings.